A recent meta-analysis has confirmed the efficacy of dexamethasone for the prevention of AMS (Tang et al., 2014) but there are conflicting results in the literature regarding the specific effects of dexamethasone on VEGF expression. This evidence concerns the gene VEGFA and ablepharon macrostomia syndrome.